Reported Reactions

Devices › Aid, surgical, viscoelastic

Device brand name · Aid surgical viscoelastic

Duovisc: medical device reports filed with FDA

160 reports name it, 1999–2017. Manufacturer given most often on reports: Alcon - Belgium/ Alcon-Couvreur. Product code LZP.

160
device reports naming the brand
0% of all MAUDE reports · about 6 a year
0
reports, 12 months to August 2026
0 in the 12 months before
3.8%
classified as malfunction
30.2% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

160 medical device reports received by FDA name the brand "Duovisc" (aid surgical viscoelastic); the manufacturer given most often on reports is Alcon - Belgium/ Alcon-Couvreur; received from September 1999 to December 2017. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (94.4%), malfunction (3.8%) and other (1.9%); across all aid, surgical, viscoelastic reports (product code LZP) death is recorded in 0% and malfunction in 30.2%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are insufficient device problem information (11.9%), device contamination with chemical or other material (1.3%) and detachment of device component (0.6%). The patient problems coded most often are inflammation, treatment with medication(s) and therapy/non-surgical treatment, additional. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Duovisc was received in the five years to August 2026; the latest was received in December 2017.

By year received

026521999: 319992006: 5220062007: 320072008: 3320082010: 1920102012: 3020122013: 320132014: 1420142017: 32017

Event type and report source

Event type, as classified on the report

Death0%0
Injury94.4%151
Malfunction3.8%6
Other1.9%3
Not given0%0

Who filed the report

Manufacturer report95%152
Voluntary report3.8%6
User facility report0%0
Distributor report0%0
Not given1.3%2

Grey bar: all 2,952 reports carrying product code LZP. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Insufficient device problem information1911.9%5.3%
Device contamination with chemical or other material21.3%7.6%
Detachment of device component10.6%4.4%
Device remains activated10.6%0%
Device, removal of (non-implant)10.6%0.3%
Foreign material10.6%0.5%
Other (for use when an appropriate device code cannot be identified)10.6%1.1%
Patient-device incompatibilitythe device did not suit the patient10.6%0.4%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Inflammationinflammation12578.1%
Treatment with medication(s)4025%
Therapy/non-surgical treatment, additional1911.9%
Other (for use when an appropriate patient code cannot be identified)148.8%
Toxic shock syndrome95.6%
Endophthalmitisinfection inside the eye63.8%
Corneal edema53.1%
Visual impairmentreduced vision53.1%
Hypopyon42.5%
Intraocular pressure increasedraised pressure in the eye42.5%
Vitrectomy42.5%
Blurred vision31.9%
Toxicity31.9%
Uveitis31.9%
Eye burn21.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureDuoviscProduct code LZPAll MAUDE reports
Reports1602,95226,136,888
Share of that pool—5.4%0%
Classified as death, per 1,000 reports009
Classified as injury94.4%68%36.2%
Classified as malfunction3.8%30.2%62.3%
Filed by the manufacturer95%96.4%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code LZP

BrandReportsLatest 12 monthsClassified as death
Healon24200.4%
VISCOAT Ophthalmic ViscoSurgical Device229400%
Viscoat22000.5%
PROVISC Ophthalmic ViscoSurgical Device175300%
Animas Insulin Infusion Pump26,29300.3%
Essure74,0724350.2%
Ligaclip Endoscopic Rotating Multiple Clip Applier 20 Large30800%
Veritas Collagen Matrix20600.5%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Duovisc reports

How many FDA reports name Duovisc?

160 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

injury (94.4%), malfunction (3.8%) and other (1.9%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

insufficient device problem information (11.9%), device contamination with chemical or other material (1.3%), detachment of device component (0.6%), device remains activated (0.6%) and device, removal of (non-implant) (0.6%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (95%) and voluntary reports (3.8%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Duovisc was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.